UBS Lux Equity Fund Biotech USD vs Atlant Stability
1. UBS Lux Equity Fund Biotech USD
2. Atlant Stability
-
Security
Atlant Stability
-
Fee
0.50%
-
ISIN
SE0002623553
-
Holdings
20
Fund Holdings
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Atlant Stability, we have 1 holdings where is the largest holding (8.89), followed by (3.16) and (3.03).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Atlant Stability.
UBS Lux Equity Fund Biotech USD |
Atlant Stability |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. 8.89 % |
2. Vertex Pharmaceuticals Inc 9.35 % |
2. 3.16 % |
3. Moderna Inc 9.21 % |
3. 3.03 % |
4. Alnylam Pharmaceuticals Inc 6.96 % |
4. 2.86 % |
5. AbbVie Inc  5.53 % |
5. 2.42 % |
6. Gilead Sciences Inc  4.66 % |
6. 2.15 % |
7. Amgen Inc 4.3 % |
7. 2.08 % |
8. BioNTech SE 4.13 % |
8. 1.98 % |
9. Karuna Therapeutics Inc 3.75 % |
9. 1.87 % |
10. Royalty Pharma Plc 3.37 % |
10. 1.76 % |
- |
11. 1.65 % |
- |
12. 1.65 % |
- |
13. 1.54 % |
- |
14. 1.49 % |
- |
15. 1.47 % |
- |
16. 1.46 % |
- |
17. 1.44 % |
- |
18. 1.4 % |
- |
19. 1.35 % |
- |
20. 1.31 % |
The list of fund holdings was last updated on June 5, 2025.